trending Market Intelligence /marketintelligence/en/news-insights/trending/RfGZV1qyCodbwY22Ib1-Dg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Novartis' Alcon unit acquires US lens implant maker PowerVision

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Six trends shaping the industries and sectors we cover in 2021


Novartis' Alcon unit acquires US lens implant maker PowerVision

Novartis AG's Alcon Inc. acquired U.S. medical device company PowerVision Inc. for $285 million.

PowerVision is a privately held company focused on creating fluid-based intraocular lens implants, which restores the vision of people affected by cataracts and/or presbyopia, the eyes' inability to focus up close.

Alcon, the eye care division being spun out of Swiss drugmaker Novartis, will make additional payments to PowerVision upon achievement of certain regulatory and commercial milestones starting in 2023. The acquisition does not have any effect on Alcon's 2023 financial guidance.

PowerVision's intraocular lens technology will be commercially available after significant additional development and clinical trials, Alcon said.